Non-Invasive Positive Pressure Ventilation (NIV/BiPAP/CPAP)
Comprehensive emergency evaluation and protocolized application of Non-Invasive Ventilation (NIV): continuous positive airway pressure (CPAP) vs. bilevel positive airway pressure (BiPAP/EPAP and IPAP); physiological mechanisms of afterload reduction in Acute Cardiogenic Pulmonary Edema (ACPE), unloading the work of breathing and reducing PaCO2 in severe COPD exacerbations, precise interface selection and fitting, absolute and relative contraindications, and clinical failure triggers requiring emergent endotracheal intubation.
Resuscitation Quick Actions • First 2 Minutes
Two Proven Indications
1) Acute Cardiogenic Pulmonary Edema (ACPE) and 2) Severe COPD Exacerbation with respiratory acidosis (pH < 7.35, PaCO2 > 45)
Initial BiPAP Settings
IPAP: 10 to 12 cmH2O (ventilation/unloading); EPAP: 4 to 6 cmH2O (oxygenation/PEEP); titrate IPAP up to 15–20 for high PaCO2
Initial CPAP Setting
Start at 5 to 10 cmH2O; excellent for pure hypoxemic acute cardiogenic pulmonary edema without hypercapnia
Absolute Contraindications
Respiratory arrest, unmanageable vomiting, active upper GI bleed, severe facial trauma/burns, GCS < 8, copious airway secretions
1-Hour Trial Rule
Recheck blood gas at 60 minutes: if pH, PaCO2, or respiratory rate fail to improve, ABORT NIV AND INTUBATE IMMEDIATELY
Delayed Intubation Trap
Prolonging a failing NIV trial in severe pneumonia or ARDS increases mortality; intubate promptly if patient tires or desaturates
Bottom-Line Clinical Pearl
Non-Invasive Ventilation (NIV) is the primary first-line respiratory therapy for TWO distinct emergency conditions: (1) Acute Cardiogenic Pulmonary Edema (ACPE/flash pulmonary edema) and (2) Severe COPD exacerbations with acute hypercapnic respiratory acidosis (pH < 7.35, PaCO2 > 45 mmHg). In ACPE, CPAP or BiPAP (EPAP 5–10 cmH2O) increases intrathoracic pressure, dramatically decreasing right and left ventricular afterload, reducing preload, and pushing alveolar fluid back into pulmonary capillaries. In COPD, IPAP (10–15 cmH2O) overcomes intrinsic PEEP and unloads fatigued diaphragmatic muscles, reducing the need for intubation by > 60% and cutting in-hospital mortality in half. Absolute contraindications: cardiac/respiratory arrest, severe encephalopathy (GCS < 8), facial trauma, vomiting, or high aspiration risk.
Non-invasive positive pressure ventilation (NIV) delivers pressurized gas to the airways via an airtight oronasal or full-face mask interface without endotracheal intubation. The physiologic benefits are divided into two distinct pressure components:
| Pressure Component | Primary Setting & Normal Range | Physiologic & Hemodynamic Effect |
|---|---|---|
| Expiratory Positive Airway Pressure (EPAP)/CPAP | 5 to 10 cmH2O | Recruits collapsed, fluid-filled alveoli, increasing Functional Residual Capacity (FRC); overcomes intrinsic PEEP ($PEEP_i$); improves ventilation-perfusion matching; increases intrathoracic pressure, which decreases systemic venous return (preload) and dramatically decreases left ventricular transmural systolic wall tension (afterload), improving cardiac output in acute heart failure. |
| Inspiratory Positive Airway Pressure (IPAP) | 10 to 20 cmH2O (Pressure Support = $IPAP - EPAP$) | Delivers positive pressure during spontaneous patient inhalation, unloading the diaphragm and accessory intercostal muscles; increases alveolar tidal volume, blows off retained $CO_2$, and rapidly reverses acute respiratory muscle fatigue. |
| Clinical Emergency Condition | Preferred Modality & Initial Settings | Evidence & Mortality Impact |
|---|---|---|
| Acute Cardiogenic Pulmonary Edema (ACPE) | CPAP 5–10 cmH2O OR BiPAP (IPAP 10, EPAP 5 cmH2O) | Reduces intubation rates by $> 60\%$ and significantly reduces hospital mortality. Afterload reduction is immediate, complementing sublingual/IV nitroglycerin. |
| Acute COPD Exacerbation with Hypercapnia | BiPAP: Start IPAP 12 cmH2O, EPAP 5 cmH2O; titrate IPAP up to 16–20 cmH2O to reduce $PaCO_2$ | Class I, Level A Evidence: Decreases endotracheal intubation rates, reduces ICU length of stay, and reduces in-hospital mortality by $> 50\%$ in patients with $pH < 7.35$ and $PaCO_2 > 45\text{ mmHg}$. |
| Immunocompromised Hypoxemic Respiratory Failure | BiPAP or High-Flow Nasal Cannula (HFNC) | Avoids intubation-associated ventilator-associated pneumonia (VAP) in hematology/oncology or transplant patients. |
Critical Pitfall / Contraindication
THE 60-MINUTE NIV FAILURE CHECKPOINT: Never leave a patient on NIV without re-evaluating objective parameters. Obtain an arterial or venous blood gas (ABG/VBG) at 60 minutes. If the arterial pH remains < 7.25, PaCO2 continues to rise, the patient exhibits worsening tachypnea or diaphoresis, or Glasgow Coma Scale deteriorates, DECLARE NIV FAILURE AND INTUBATE IMMEDIATELY. Delaying mandatory intubation in failing NIV trials significantly increases cardiac arrest and mortality rates.
Test Your Non-Invasive Positive Pressure Ventilation (NIV/BiPAP/CPAP) Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Acute Severe Asthma & COPD
Pharmacotherapy and pathophysiology of COPD.
Open Protocol Related EM ProtocolAcute Heart Failure & Cardiogenic Shock
Vasodilators and afterload reduction in flash pulmonary edema.
Open Protocol Related EM ProtocolARDS & Lung-Protective Ventilation
Invasive ventilation when NIV fails in hypoxemia.
Open Protocol